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Carotid ultrasound findings as a predictor of long-
term survival after abdominal aortic aneurysm
repair: A 14-year prospective study
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Marios Daskalopoulos, MD, Alexios Nikolaou, MD, and Alkiviadis G. Kostakis, MD, Athens, Greece
Purpose: Several factors have been related to long-term survival after open abdominal aortic aneurysm (AAA) repair. The
effect of carotid stenosis on outcome has not yet been examined. We performed an open prospective study to evaluate the
prognostic significance of carotid stenosis on long-term survival of patients who had undergone elective operative repair
of AAA.
Methods: Two hundred eight patients who underwent elective open AAA repair in our department between March 1987
and December 2001 were included in the study. All patients were evaluated preoperatively with color duplex ultrasound
(US) scanning of the carotid arteries, and were followed up with clinical examination and carotid duplex US scanning 1
month after the operation and every 6 months thereafter. Median duration of follow-up was 50 months (range, 5-181
months). Cardiovascular morbidity and mortality, as well as all causes of mortality, were recorded and analyzed with
regard to traditional risk factors and carotid US findings.
Results: Twenty-seven fatal and 46 nonfatal cardiovascular events were recorded. Both univariate and multivariate analysis
showed that carotid stenosis 50% or greater and echolucent plaque were significantly associated with cardiovascular
mortality and morbidity. Carotid stenosis was a stronger predictor of cardiovascular death than was ankle/brachial index.
Age, hypercholesterolemia, coronary artery disease, and diabetes mellitus were also associated with higher mortality and
morbidity from cardiovascular causes.
Conclusion: Patients electively operated on for AAA repair and with stenosis 50% or greater and echolucent plaque at
duplex US scanning are at significantly increased risk for cardiovascular mortality and morbidity. Carotid US can
therefore be used to select a subgroup of patients with AAA who might benefit from medical intervention, including
antiplatelet and lipid-lowering agents. (J Vasc Surg 2003;38:1220-5.)
Abdominal aortic aneurysm (AAA) is a degenerative
disorder that traditionally has been attributed to atheroscle-
rotic disease. The atherosclerotic cause of AAA is supported
by clinical, pathologic, and experimental data. Patients with
peripheral arterial occlusive disease have a high prevalence
of AAA,1-5 atherosclerotic changes are consistently found
in the aneurysm sac, and atherosclerotic diet has resulted in
aneurysm formation in an experimental model.6 On the
other hand, in many patients with extensive atherosclerosis
of the aorta, aneurysm never develops, and their risk factor
profile is different from that of patients with AAA.7-10 In
addition, noncardiovascular diseases, such as inguinal her-
nia and chronic obstructive pulmonary disease, are fre-
quently present in patients with AAA, signifying that con-
nective tissue disorders may have a role in AAA
formation.11,12 On the basis of these observations, it has
been suggested that AAA may be divided into two patho-
logic entities: one with primarily atherosclerotic origin and
a predominantly nonatherosclerotic subtype.13 Although
such classification may be of little value with regard to
surgical treatment, these AAA subtypes may be associated
with different long-term prognosis after surgical repair.
Two methods have been suggested for differentiation
between atherosclerotic and nonatherosclerotic AAA: an-
kle/brachial index (ABI), with a value of 0.90 separating
the two groups, and degree of internal carotid artery (ICA)
stenosis, with 50% as the cutoff point.13 ABI is also an
important prognostic indicator,14 whereas the prognostic
significance of carotid stenosis in patients with AAA has not
been examined yet. To evaluate the effect of carotid steno-
sis on long-term survival after elective open AAA repair, we
performed an open prospective study.
METHODS
Two hundred eight patients who underwent elective
open AAA repair in our department between March 1987
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and December 2001 were included in the study. The study
was approved by the hospital ethics committee, and in-
formed consent was obtained from each patient. To ensure
adequacy of follow-up, only patients residing in Athens
were selected to participate in the study. Indication for
surgery was AAA diameter at least 5 cm. At entry into the
study a complete medical history was taken and risk factors
were recorded (Table I), including age, gender, coronary
artery disease (CAD; angina pectoris, myocardial infarction
(MI), coronary artery bypass grafting, percutaneous trans-
luminal coronary angioplasty), diabetes mellitus (con-
trolled with diet, oral hypoglycemic agents, or insulin;
fasting glucose level 7 mmol/L), hypercholesterolemia
(total cholesterol 5.2 mmol/L), hypertension (blood
pressure 160 mm Hg systolic or 95 mm Hg diastolic),
and smoking history (current or past).
Apart from routine preoperative evaluation, baseline
assessment included measurement of ankle/brachial sys-
tolic pressure index and color duplex US scanning of the
carotid arteries. Systolic blood pressure in both arms and
ankles was measured with a handheld Doppler scanning
device (8 MHz; Huntleigh Doppler, Cardiff, Wales) and a
standard mercury sphygmomanometer. A single measure-
ment by an experienced examiner was considered sufficient
in each patient. The lower of the right and left index values
was used for analysis. ABI could not be calculated in one
patient, because of incompressible arterial walls.
Color duplex US scans of the carotid arteries were
obtained with an ATL Interspec Apogee scanner with a 7.5
MHz probe (Advanced Technology Laboratories, Bothel,
Wash). All scanning was performed by the same examiner.
The most severe stenosis in either ICA was used for analysis.
The US characteristics of the plaque were also recorded,
with plaque classified into five categories.15,16 Intraob-
server variability of plaque characterization in our labora-
tory is good, as previously reported.17
All patients were followed up with clinical examination
and carotid duplex US scanning 1 month after the opera-
tion and every 6 months thereafter. Cardiovascular morbid-
ity and mortality, and all-cause mortality were recorded and
analyzed with regard to traditional risk factors, ABI, and
carotid US findings. Criteria used to define cardiovascular
events were adapted from those proposed by the American
Heart Association.18,19 The effect of these variables on
cardiovascular morbidity and mortality, as well as all-cause
mortality, was assessed with the Kaplan-Meier method.
Curves depicting event-free survival were drawn for each
variable and compared with the log-rank test. Continuous
variables such as age and ABI were converted into dichot-
omous variables, with cutoff points of 70 years and 0.90,
respectively. Graded parameters with more than two cate-
gories, such as carotid stenosis and plaque type, were also
transformed into dichotomous variables. In the case of
carotid stenosis, a cutoff point of 50% was used, whereas in
the case of plaque type, types I and II were combined (low
echogenicity group) and compared with combined types
III and IV (high echogenicity group). After determining
univariate associations, multivariate (Cox regression) anal-
ysis was used to determine independence of associations.
Plaque type was entered in the multivariate model as a
dummy parameter, with three values: 0, no assessable
plaque; 1, echolucent plaque; and 2, echogenic plaque. P
.05 was considered statistically significant in all tests.
RESULTS
At entry into the study, 156 patients (75%) had carotid
stenosis less than 50% and 52 patients (25%) had stenosis
50% or greater. Carotid stenosis ranged from 0% to 70%,
and was asymptomatic in all patients. Thirty-one plaques
(15%) were uniformly echolucent (type I), 48 (23%) were
predominantly echolucent (type II), 46 (22%) were pre-
dominantly echogenic (type III), and 39 (19%) were uni-
formly echogenic (type IV); we did not encounter any type
V plaque (plaque that cannot be classified because of heavy
calcification and acoustic shadows). The remaining 44 pa-
tients (21%) did not have any assessable carotid plaque.
Median ABI was 0.96 (range, 0.45-1.35).
Two patients (1%) died within 30 days of surgery, of
multiple organ failure and acute renal failure, respectively.
The remaining 206 patients were followed up for a median
of 50 months (range, 5-181 months), for total follow-up of
869 patient-years. Eleven patients (5.3%) were lost to fol-
low-up.
Forty-eight deaths were recorded during follow-up.
Twenty-seven patients died of cardiovascular events (21,
cardiac disease; 6, stroke). On the basis of diagnostic crite-
ria for acute cardiovascular events,17,18 3 patients had def-
inite fatal MI, verified at autopsy; 8 patients had definite
fatal MI diagnosed with electrocardiography and abnormal
cardiac enzyme concentrations; 6 patients had definite sud-
den death due to coronary heart disease, as demonstrated
by severe cardiac symptoms and absence of nonatheroscle-
rotic disease; and 4 patients had definite fatal coronary heart
disease, according to the death certificate and supported by
a history of MI and absence of nonatherosclerotic disease.
Diagnosis of fatal stroke was verified in all patients at
physical examination, and was supported by CT findings in
four patients.
Cumulative freedom from death due to cardiovascular
events at 8 years after AAA repair was 77%. Kaplan-Meier
analysis with the log-rank test (Fig 1) showed that cumu-
lative freedom from cardiovascular death was significantly
lower in patients with carotid stenosis 50% or greater (58%





Gender (M/F) 192/16 92/8
Coronary artery disease 87 42
Diabetes mellitus 75 36
Hypertension 144 69
Hypercholesterolemia 95 46
History of smoking 148 71
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at 8 years) than in patients with carotid stenosis less than
50% (84%; P .007). Cumulative freedom from cardiovas-
cular death was also significantly lower in patients with
echolucent plaque (63% vs 85%; P  .03; Fig 2), patients
with ABI less than 0.90 (65% vs 89%; P .008), patients 70
years or older (45% vs 93%; P  .0001), and patients with
known CAD (64% vs 88%; P .03), diabetes mellitus (65%
vs 82%; P  .05), or hypercholesterolemia (66% vs 85%; P
 .05). Gender, smoking, and hypertension were not sig-
nificantly associated with cardiovascular mortality after
AAA repair.
Forty-six patients had at least one nonfatal cardiovas-
cular event during follow-up, resulting in cumulative free-
dom from cardiovascular morbidity of 50% at 8 years of
follow-up. Thirty-one of these patients had nonfatal MI, 7
had nonfatal stroke, 4 had transient ischemic attack, and 4
patients had both MI and stroke. Diagnosis was verified in
all cases according to hospital records. Univariate analysis
showed that cumulative freedom from cardiovascular mor-
bidity was significantly lower in patients with carotid steno-
sis 50% or greater (31% vs 58% at 8 years; P  .002; Fig 3)
and in those with echolucent plaque (40% vs 50%; P 
.005; Fig 4). Cumulative freedom from nonfatal cardiovas-
cular events was also significantly lower in patients with
known CAD (41% vs 57%; P .01), diabetes mellitus (30%
vs 57%; P  .05), hypercholesterolemia (35% vs 60%; P 
.05), hypertension (44% vs 76%; P  .05), and ABI less
than .90 (39% vs 59%; P  .01), and in patients aged 70
years or older (39% vs 56%; P  .0001). Gender and
smoking were not significantly associated with cardiovascu-
lar morbidity after AAA repair.
Fig 1. Cumulative freedom from death from cardiovascular
causes, relative to degree of carotid stenosis.
Fig 2. Cumulative freedom from death from cardiovascular
causes, relative to type of carotid plaque as noted at ultrasonogra-
phy.
Fig 3. Cumulative freedom from cardiovascular morbidity, rela-
tive to degree of carotid stenosis.
Fig 4. Cumulative freedom from cardiovascular morbidity, rela-
tive to type of carotid plaque as noted at ultrasonography.
JOURNAL OF VASCULAR SURGERY
December 20031222 Liapis et al
All parameters found to be of prognostic significance in
univariate analysis were entered into a multivariate model
(Cox regression analysis), to assess independence of associ-
ations. The results of the analysis verified that the degree of
carotid stenosis and the US characteristics of the carotid
plaque were independently associated with cardiovascular
mortality (Table II) and morbidity (Table III). Age, CAD,
diabetes mellitus, hypercholesterolemia, and ABI were also
significant, independent predictors of death due to cardio-
vascular causes. In particular, age was the most significant
predictor of long-term cardiovascular mortality, with each
year of age adding a 27% probability of death from cardio-
vascular cause. Hypercholesterolemia was the second most
significant risk factor, associated with a more than fourfold
increase in probability of cardiovascular death. Echolucent
plaque (hazard ratio [HR], 3.83), carotid stenosis 50% or
greater (HR, 3.61), known CAD (HR, 2.93), ABI less than
0.90 (HR, 2.81), and diabetes mellitus (HR, 2.60) fol-
lowed in descending order. Age was the most significant
independent predictor of cardiovascular morbidity (HR,
1.15), followed by hypercholesterolemia (HR, 4.31), ca-
rotid stenosis 50% or greater (HR, 4.04), hypertension
(HR, 3.12), echolucent plaque (HR, 2.82), diabetes mel-
litus (HR, 2.77), and history of CAD (HR, 2.65). ABI, on
the other hand, lost its independent prognostic significance
when entered in the multivariate model.
There were 21 deaths from noncardiovascular causes:
14 patients died of cancer, 2 died of renal failure, 1 died of
chronic obstructive pulmonary disease, 1 died of pulmo-
nary infection, and 3 died of unknown cause. Univariate
analysis showed that of the recorded risk factors only age 70
years or older was significantly associated with mortality
from noncardiovascular causes (P  .0005).
Overall survival at 8 years of follow-up was 60%, as
calculated by life-table analysis, and was significantly af-
fected by carotid stenosis 50% or greater (42% vs 67%; P 
.01), age 70 years or older (24% vs 81%; P .0001), known
CAD (50% vs 68%; P  .01), and ABI  .90 (46% vs 73%;
P  .05). At multivariate analysis, however, none of these
risk factors proved to be independently associated with
all-cause mortality, except for age (HR, 1.21; 95% confi-
dence interval [CI], 1.14-1.28).
DISCUSSION
Age, CAD, hypertension, chronic renal failure and
previous history of cerebrovascular events are among the
most commonly cited factors related to long-term survival
after elective AAA repair.20-27 However, there is unanimity
only regarding the predictive value of age, and no consen-
sus regarding the prognostic value of other major risk
factors, including hypertension and even CAD.21-24 The
inability of several studies to determine the negative influ-
ence of well-established atherosclerotic risk factors on sur-
vival has been attributed to many reasons, such as small
number of patients, short follow-up, or inadequate preop-
erative detection of CAD.22 Apart from these possible
explanations, we believe that the inclusion of deaths not
related to complications of atherosclerosis in the outcome
measures reduces the ability of a study to detect the dele-
terious effect of atherosclerotic risk factors. In line with this,
cancer was the principal cause of late mortality after success-
ful AAA repair in some studies.20-22 For these reasons, in
the present study we chose to focus on mortality due to
cardiovascular events.
The most important finding is that color duplex US
scanning of the carotid arteries can be used to predict
long-term mortality due to cardiovascular events in patients
undergoing elective AAA repair. Simons et al13 showed
that common carotid intima-media thickness (IMT) can be
used to differentiate between two groups of patients with
AAA, that is, one with IMT greater than 0.90 mm, which is
more likely to be associated with ABI 0.90 or less and ICA
stenosis 50% or greater, and another group with IMT 0.90
mm or less, which is more likely associated with ABI greater
than 0.90 and ICA stenosis less than 50%. Examination of
long-term outcome in these subgroups of patients was
beyond the scope of our study. Recently Powell et al14
examined the prognostic value of ABI in patients with
AAA. A clear association was found between ABI and worse
survival, with the all-cause mortality risk increasing by 25%
per 0.2 unit decrease in ABI. Lower ABI was also strongly
associated with cardiovascular death, with an increase of
28% in cardiovascular mortality per 0.2 unit decrease in
ABI.
Table III. Results of Cox regression analysis with






Age* .0001 1.15 1.08-1.23
Coronary artery disease .005 2.65 1.34-5.22
Diabetes mellitus .002 2.77 1.45-5.31
Hypercholesterolemia .0001 4.31 2.13-8.74
Hypertension .02 3.12 1.24-7.83
Ankle/brachial index .07 1.89 0.95-3.74
Carotid stenosis .0007 4.04 1.81-9.03
Plaque type† .008 2.82 1.31-6.10
*Age used as continuous variable.
†Echolucent vs echogenic.
Table II. Results of Cox regression analysis with







Age* .0001 1.27 1.17-1.39
Coronary artery disease .03 2.93 1.12-7.66
Diabetes mellitus .03 2.60 1.10-6.14
Hypercholesterolemia .003 4.64 1.71-12.59
Ankle/brachial index .05 2.81 1.02-7.75
Carotid stenosis .01 3.61 1.28-10.14
Plaque type† .03 3.83 1.17-12.53
* Age used as continuous variable.
†Echolucent vs echogenic.
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In accord with these findings, ABI was a significant
predictor of long-term cardiovascular mortality in our
study. Patients with ABI less than 0.90 had a 2.8-fold
increased risk for long-term cardiovascular death compared
with patients with ABI 0.90 or greater (HR, 2.81; 95% CI,
1.02-7.75). However, ICA stenosis 50% or greater was a
stronger predictor of cardiovascular mortality, associated
with a 3.6-fold increased incidence of cardiovascular death
(HR, 3.61; 95% CI, 1.28-10.14). These findings suggest
that carotid stenosis might be a better indicator than ABI of
generalized atherosclerosis in patients with AAA.
The most commonly used indicator of widespread ath-
erosclerosis is no doubt the common carotid IMT. Numer-
ous studies have shown that increased IMT of the carotid
artery is associated with atherosclerosis at other sites of the
arterial system,28 and some studies have also shown an
association between IMT and risk for MI or stroke.29-31
With regard to carotid stenosis, Rosfors et al32 showed that
IMT of the common carotid artery (CCA) is correlated
with presence of stenosis in the left carotid bifurcation, and
Zureik et al33 recently reported that CCA-lumen diameter,
but not CCA-IMT, is independently associated with aortic
stiffness. These findings suggest that, in addition to IMT,
carotid stenosis may be used as a surrogate marker of
generalized atherosclerosis.
One of the advantages of duplex US scanning is that,
apart from detecting degree of carotid stenosis, it provides
unique information regarding the structure of the arterial
wall and the characteristics of atherosclerotic plaque. This
information has great predictive value, because echolucent
plaque or plaque with gray scale median less than 32 or 40
is associated with higher incidence of cerebrovascular
events.16,34-38 We recently showed that echolucent plaques
are associated with higher incidence of future cardiovascu-
lar events in a population of patients undergoing carotid
endarterectomy.17 On the basis of these findings, we sug-
gested that there might be a correlation between plaque
echolucency in the carotid arteries and plaque instability
and rupture in the coronary arteries. The results of the
present study lend further support to this theory, in that
patients with AAA and echolucent carotid plaque had an
almost fourfold increase in cardiovascular mortality com-
pared with patients with AAA and echogenic plaque.
Findings of carotid duplex scanning are of particular
interest in the context of the current guidelines for choles-
terol-lowering therapy. According to the Adult Treatment
Panel III of the National Cholesterol Education Pro-
gram,39 carotid stenosis greater than 50% is defined as a
coronary heart disease equivalent, and automatically desig-
nates a patient to a higher risk category. This practically
means a lower low-density lipoprotein cholesterol cutoff
point for initiation of therapeutic lifestyle changes (100
mg/dL) and drug therapy (130 mg/dL) and more ag-
gressive treatment goals (100 mg/dL). Best medical
treatment of these patients should also include aspirin or
other oral antiplatelet drug, because the beneficial effects of
these agents are well recognized in most patients with
atherosclerotic disease, including those with carotid steno-
sis.40
Better risk assessment also means better stratification of
the need for follow-up. We currently advocate annual fol-
low-up for patients with AAA with carotid stenosis 50% or
greater or echolucent plaque, and biennial testing for pa-
tients with carotid stenosis less than 50% and echogenic
plaque. Although our study was not designed to test the
cost-effectiveness of this strategy, we believe the long-term
benefits of an accurate, noninvasive, and relatively inexpen-
sive method of risk assessment outweighs its initial cost.
In conclusion, a single preoperative carotid duplex US
scan may be valuable in patients undergoing AAA repair, to
differentiate between patients with AAA as a local manifes-
tation and those with AAA as part of generalized athero-
sclerosis, because the long-term course differs in these two
groups. Patients with AAA with carotid stenosis 50% or
greater, indicative of widespread atherosclerosis, and those
with echolucent plaque, indicative of plaque instability, are
at significantly increased risk for cardiovascular mortality
and consequently are in greater need of further evaluation,
rigorous follow-up, and risk factor modification.
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